CORCEPT THERAPEUTICS INC Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
CORCEPT THERAPEUTICS INC (CORT) reported Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 4.10 million shares for the 1-month period ending 2024-02-29, per its 10-Q filed 2024-10-30.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2024-10-30
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2021 was 4.67M shares, a 1.90% increase from fiscal 2020.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2020 was 4.58M shares, a 0.41% decline from fiscal 2019.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2019 was 4.60M shares, a 0.26% increase from fiscal 2018.
- CORCEPT THERAPEUTICS INC share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2018 was 4.59M shares, a 1.80% increase from fiscal 2017.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 12 month |
|---|---|---|
| 2024-02-29 | 4.10M shares 10-Q · filed 2024-10-30 | |
| 2021-12-31 | 4.67M shares 10-K · filed 2022-02-15 | |
| 2020-12-31 | 4.58M shares 10-K · filed 2021-02-23 | |
| 2019-12-31 | 4.60M shares 10-K · filed 2020-02-24 | |
| 2018-12-31 | 4.59M shares 10-K · filed 2020-02-24 | |
| 2017-12-31 | 4.51M shares 10-K · filed 2020-02-24 | |
| 2016-12-31 | 4.39M shares 10-K · filed 2019-02-26 | |
| 2015-12-31 | 4.06M shares 10-K · filed 2018-02-28 | |
| 2014-12-31 | 3.99M shares 10-K · filed 2017-03-06 | |
| 2013-12-31 | 3.99M shares 10-K · filed 2016-03-10 | |
| 2013-01-30 | 3.99M shares 10-Q · filed 2013-05-08 | |
| 2012-12-31 | 3.37M shares 10-K · filed 2015-03-13 | |
| 2011-12-31 | 2.90M shares 10-K · filed 2014-03-14 | |
| 2010-12-31 | 2.50M shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |